Author

Alp Bayrak

University of TübingenORCID 0000-0003-4752-2730Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Assay:flow cytometry· 1

Frequent Co-Authors

Anne‐Katrin RohlfingiD· 2 shared David SchaaleiD· 2 shared Manuel SigleiD· 2 shared Meinrad Paul GawaziD· 2 shared Stefan LauferiD· 2 shared Tatsiana CastoriD· 2 shared Thanigaimalai PillaiyariD· 2 shared Valerie DicentaiD· 2 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

Anne‐Katrin RohlfingORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cell BiologyFEBS JournalPeer-reviewedOct 10, 2024

Hemin-induced platelet activation is regulated via ACKR3 chemokine surface receptor - implications for passivation of vulnerable atherosclerotic plaque

Zoi Laspa, Valerie Dicenta, David Schaale…·Meinrad Paul Gawaz

This study shows hemin activates platelets and promotes thrombosis, which can be inhibited by ACKR3 agonists, suggesting a potential therapeutic strategy for atherosclerotic plaque vulnerability.

8 citations

humanflow cytometry

𝕏 PostBluesky

PhysiologyEuropean Journal of Clinical InvestigationPeer-reviewedOct 7, 2024

ACKR3 agonism induces heterodimerization with chemokine receptor CXCR4 and attenuates platelet function

Valerie Dicenta, Zoi Laspa, David Schaale…·Anne‐Katrin Rohlfing

This study shows that ACKR3 agonism promotes heterodimerization with CXCR4 in platelets, reducing platelet activation and thrombus formation by modulating CXCR4 signaling.

7 citations

humanexperimental assay

𝕏 PostBluesky